Celldex Presents Positive Preclinical Data from CDX-622
- ByInvesting.com-
Celldex (NASDAQ:CLDX) Therapeutics, Inc. (CLDX) today announced preclinical data from CDX-622, the Company’s bispecific antibody with dual targeting of the alarmin TSLP and stem...